Przegląd Gastroenterologiczny

Abstract

2/2023 vol. 18
Research paper

Long-lasting dyspeptic symptoms – another consequence of the COVID-19 pandemic?

  1. Clinical Department of Internal Medicine and Gastroenterology with Inflammatory Bowel Disease Unit, Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland
  2. Department of Internal Medicine and Hypertension, Medical University of Bialystok, Bialystok, Poland
  3. Department of Hypertension, Gastroenterology, and Internal Medicine, Medical University of Bialystok Clinical Hospital, Bialystok, Poland
  4. Department of Gastroenterology, Pomeranian Medical University, Szczecin, Poland
  5. Collegium Medicum, Jan Kochanowski University, Kielce, Poland
Gastroenterology Rev 2023; 18 (2): 175–182
Online publish date: 2023/07/27
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Introduction

It is known that the virus SARS-CoV-2 can attack the gastrointestinal (GI) tract and induce gastroenteritis. This can trigger a wide variety of disorders of gut-brain interaction (DGBIs) or functional gastrointestinal disorders (FGIDs), including post-infectious dyspepsia, which remains underestimated.

Aim

To estimate the prevalence of dyspeptic symptoms following COVID-19, immediately after discharge and 3, 6, and 9 months after hospitalization.

Material and methods

A prospective, single-centre evaluation of questions regarding functional dyspepsia (FD) as assessed by the Gastroduodenal Module of ROME IV Diagnostic Questionnaire for Adult FGIDs among 320 patients who had had COVID-19.

Results

The FD ROME IV criteria were met at the respective time-points by 0.0% (0), 4.8% (12), 3.2% (8), and 3.2% (8) of cases. However, the presence of GI symptoms that suggested FD but did not meet the timeframe ROME IV criteria for FD were found in 9.6% (24), 23.5% (59), 20.7% (52), and 20.7% (52) of cases, respectively.

Conclusions

The presence and persistence of gastrointestinal dyspeptic symptoms following COVID-19 is a significant problem. The timeframe of the Rome IV criteria may underestimate the number of patients with persistent dyspeptic symptoms following COVID-19 disease.

Share
without publication fees